Evoke Pharma Stock Price Prediction
| EVOK Stock | USD 4.50 0.06 1.32% |
Oversold Vs Overbought
52
Oversold | Overbought |
EPS Estimate Next Quarter (0.25) | EPS Estimate Current Year (3.98) | EPS Estimate Next Year 0.48 | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.38) |
Using Evoke Pharma hype-based prediction, you can estimate the value of Evoke Pharma from the perspective of Evoke Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evoke Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Evoke because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evoke Pharma after-hype prediction price | USD 4.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evoke |
Evoke Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Evoke Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evoke Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Evoke Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evoke Pharma Estimiated After-Hype Price Volatility
In the context of predicting Evoke Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evoke Pharma's historical news coverage. Evoke Pharma's after-hype downside and upside margins for the prediction period are 0.23 and 10.80, respectively. We have considered Evoke Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evoke Pharma is very risky at this time. Analysis and calculation of next after-hype price of Evoke Pharma is based on 3 months time horizon.
Evoke Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Evoke Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evoke Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evoke Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 6.30 | 0.00 | 0.01 | 7 Events / Month | 12 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.50 | 4.50 | 0.00 |
|
Evoke Pharma Hype Timeline
Evoke Pharma is currently traded for 4.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Evoke is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.14%. %. The volatility of related hype on Evoke Pharma is about 7254.55%, with the expected price after the next announcement by competition of 4.49. About 17.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evoke Pharma recorded a loss per share of 10.13. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 1st of August 2024. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Evoke Pharma Basic Forecasting Models to cross-verify your projections.Evoke Pharma Related Hype Analysis
Having access to credible news sources related to Evoke Pharma's direct competition is more important than ever and may enhance your ability to predict Evoke Pharma's future price movements. Getting to know how Evoke Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evoke Pharma may potentially react to the hype associated with one of its peers.
Evoke Pharma Additional Predictive Modules
Most predictive techniques to examine Evoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evoke using various technical indicators. When you analyze Evoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evoke Pharma Predictive Indicators
The successful prediction of Evoke Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evoke Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evoke Pharma based on analysis of Evoke Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evoke Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evoke Pharma's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.38 | 0.43 | 0.12 | 0.2 | Days Of Inventory On Hand | 206.39 | 285.16 | 871.17 | 648.49 |
Story Coverage note for Evoke Pharma
The number of cover stories for Evoke Pharma depends on current market conditions and Evoke Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evoke Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evoke Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Evoke Pharma Short Properties
Evoke Pharma's future price predictability will typically decrease when Evoke Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evoke Pharma often depends not only on the future outlook of the potential Evoke Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evoke Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 278.6 K | |
| Cash And Short Term Investments | 4.7 M |
Check out Evoke Pharma Basic Forecasting Models to cross-verify your projections. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.